Cardiomyocyte Degeneration With Calpain Deficiency Reveals a Critical Role in Protein Homeostasis
暂无分享,去创建一个
G. Dorn | J. Robbins | A. Diwan | H. Osińska | H. Hahn | J. Meléndez | Amy M. Odley | R. Lynch | Y. Marreez | A. Galvez | A. Gálvez | Yehia Marreez
[1] G. Sommer,et al. Reference , 2008 .
[2] S. Vatner,et al. Activation of the Cardiac Proteasome During Pressure Overload Promotes Ventricular Hypertrophy , 2006, Circulation.
[3] C. Patterson,et al. Into the heart: the emerging role of the ubiquitin-proteasome system. , 2006, Journal of molecular and cellular cardiology.
[4] C. Tsai,et al. Purification and Characterization , 2006 .
[5] J. Papp,et al. Calpain-1-sensitive myofibrillar proteins of the human myocardium , 2005, Molecular and Cellular Biochemistry.
[6] E. Kudryashova,et al. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.
[7] O. Ritter,et al. Targeted Proteolysis Sustains Calcineurin Activation , 2005, Circulation.
[8] G. Dorn,et al. Physiological Growth Synergizes With Pathological Genes in Experimental Cardiomyopathy , 2004, Circulation research.
[9] A. Goldberg,et al. Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.
[10] M. Zatz,et al. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A , 2003, Journal of clinical pathology.
[11] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[12] Q. Liang,et al. Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.
[13] Ken-ichi Yoshida,et al. Phosphoinositide 3-kinase accelerates calpain-dependent proteolysis of fodrin during hypoxic cell death. , 2002, Journal of biochemistry.
[14] E. Sztul,et al. Hassles with Taking Out the Garbage: Aggravating Aggresomes , 2002, Traffic.
[15] H. Hatch,et al. Casein zymography of calpains using a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-imidazole buffer. , 2002, Analytical biochemistry.
[16] S. Sandmann,et al. Activity profile of calpains I and II in chronically infarcted rat myocardium – influence of the calpain inhibitor CAL 9961 , 2002, British journal of pharmacology.
[17] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[18] John Calvin Reed,et al. Bid Is Cleaved by Calpain to an Active Fragment in Vitro and during Myocardial Ischemia/Reperfusion* , 2001, The Journal of Biological Chemistry.
[19] M. Hori,et al. Intracellular calcium level required for calpain activation in a single myocardial cell. , 2001, Journal of molecular and cellular cardiology.
[20] Changlian Zhu,et al. Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.
[21] J. Fischer,et al. Muscle Cachexia: Current Concepts of Intracellular Mechanisms and Molecular Regulation , 2001, Annals of surgery.
[22] J. Cohn,et al. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.
[23] J. Beckmann,et al. Calpainopathy-a survey of mutations and polymorphisms. , 1999, American journal of human genetics.
[24] M. Matsuzaki,et al. Calpain inhibitor-1 reduces infarct size and DNA fragmentation of myocardium in ischemic/reperfused rat heart. , 1999, Journal of cardiovascular pharmacology.
[25] R. Kopito,et al. Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.
[26] J. Beckmann,et al. Clinical, pathological, and genetic features of limb‐girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families , 1998, Muscle & nerve.
[27] S. Schreiber,et al. Lactacystin, Proteasome Function, and Cell Fate* , 1998, The Journal of Biological Chemistry.
[28] Wolfgang Baumeister,et al. The Proteasome: Paradigm of a Self-Compartmentalizing Protease , 1998, Cell.
[29] G. Dorn,et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .
[30] D. Atar,et al. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.
[31] B. Trapnell,et al. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.
[32] A. Goldberg,et al. Importance of the ATP-Ubiquitin-Proteasome Pathway in the Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts* , 1996, The Journal of Biological Chemistry.
[33] A. Goldberg. Functions of the proteasome: the lysis at the end of the tunnel. , 1995, Science.
[34] Isabelle Richard,et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.
[35] M. Fujiwara,et al. Calpain is implicated in rat myocardial injury after ischemia or reperfusion. , 1994, Japanese circulation journal.
[36] K. Suzuki,et al. Positive regulation of mu-calpain action by polyphosphoinositides. , 1992, The Journal of biological chemistry.
[37] J. Robbins,et al. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.
[38] J. Lowe,et al. Ubiquitin in health and disease. , 1991, Biochimica et biophysica acta.
[39] D. E. Goll,et al. The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain). , 1989, The Journal of biological chemistry.
[40] Y. Nishizuka,et al. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). , 1989, The Journal of biological chemistry.
[41] P. Traub,et al. Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins , 1983, Molecular and cellular biology.
[42] K. Imahori,et al. Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization. , 1978, Journal of biochemistry.
[43] G. Dorn,et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Clark,et al. Inappropriate ubiquitin conjugation: a proposed mechanism contributing to heart failure. , 1997, Cardiovascular research.
[45] G. Majno,et al. Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.
[46] K. Suzuki,et al. Proteolysis of protein kinase C by calpain: effect of acidic phospholipids. , 1991, Biomedica biochimica acta.
[47] M. Maki,et al. Calpastatins: biochemical and molecular biological studies. , 1991, Biomedica biochimica acta.
[48] B. Nadal-Ginard,et al. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.